Tandon A, Shahzad K, Pathak S, Oommen C M, Nunes Q M, Smart N
Department of Surgery, Aintree University Hospital , Liverpool , UK.
Exeter Surgical Health Services Research Unit (HESRU), Royal Devon and Exeter NHS Foundation Trust , Exeter , UK.
Ann R Coll Surg Engl. 2016 Nov;98(8):568-573. doi: 10.1308/rcsann.2016.0292. Epub 2016 Sep 23.
INTRODUCTION Laparoscopic incisional and ventral hernia repair (LIVHR) is widely accepted and safe but the type of mesh used is still debated. We retrospectively compared postoperative outcomes with two different meshes commonly used in LIVHR. METHODS This is a retrospective study of patients who underwent incisional hernia repair between January 2008 and December 2010. Two meshes were used: Parietex™ Composite (Covidien, New Haven, CT, USA) and the DynaMesh-IPOM (FEG Textiltechnik mbH, Aachen, Germany). The two groups were compared with respect to recurrence rates, incidence of seroma and intestinal obstruction. RESULTS Among the 88 patients who underwent LIVHR, 75 patients (85.2%) presented with primary incisional hernia, 10 (11.4%) presented with a first recurrence and 3 (3.4%) presented with a second recurrence. Median follow-up was 53.6 months (range 40-61 months). 12.9% of patients had recurrence in the Parietex™ Composite mesh group (n=62) in comparison to 3.8% in the DynaMesh-IPOM mesh group (n=26; P=0.20). DynaMesh-IPOM was associated with a significantly higher incidence of intestinal obstruction secondary to adhesions (11.5% vs. 0%, P=0.006) and lower incidence of seroma and haematoma formation compared to Parietex™ composite mesh group (0% vs. 6.4% of patients; P=0.185). CONCLUSIONS LIVHR is a safe and feasible technique. Dynamesh-IPOM is associated with a significantly higher incidence of adhesion related bowel obstruction, albeit with a lower incidence of recurrence, seroma and haematoma formation compared with Parietex™ Composite mesh. However, there is a need for further well-designed, multicentre randomised controlled studies to investigate the use of these meshes.
引言 腹腔镜切口疝和腹疝修补术(LIVHR)已被广泛接受且安全,但所用补片的类型仍存在争议。我们回顾性比较了LIVHR中常用的两种不同补片的术后结果。
方法 这是一项对2008年1月至2010年12月期间接受切口疝修补术患者的回顾性研究。使用了两种补片:Parietex™复合补片(美国科惠医疗公司,纽黑文,康涅狄格州)和DynaMesh-IPOM补片(德国亚琛FEG纺织技术有限公司)。比较两组的复发率、血清肿发生率和肠梗阻发生率。
结果 在88例行LIVHR的患者中,75例(85.2%)为原发性切口疝,10例(11.4%)为首次复发,3例(3.4%)为二次复发。中位随访时间为53.6个月(范围40 - 61个月)。Parietex™复合补片组(n = 62)的复发率为12.9%,而DynaMesh-IPOM补片组(n = 26)为3.8%(P = 0.20)。与Parietex™复合补片组相比,DynaMesh-IPOM补片导致粘连性肠梗阻的发生率显著更高(11.5%对0%,P = 0.006),血清肿和血肿形成的发生率更低(患者分别为0%对6.4%;P = 0.185)。
结论 LIVHR是一种安全可行的技术。与Parietex™复合补片相比,DynaMesh-IPOM补片导致粘连相关肠梗阻的发生率显著更高,尽管复发率、血清肿和血肿形成的发生率更低。然而,需要进一步设计良好的多中心随机对照研究来研究这些补片的使用情况。